Crane Company (CR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Q4 2024 sales rose 12% to $544 million, with adjusted EPS up 58% to $1.26 and adjusted operating profit up 38%, driven by both core growth and acquisitions.
Full-year 2024 sales increased 14% to $2.13 billion, with adjusted EPS up 28% to $4.88 and core sales growth of 8%.
Completed divestiture of Engineered Materials segment, focusing on Aerospace & Electronics and Process Flow Technologies.
Announced 12% increase in annual dividend and promoted Alex Alcala to Chief Operating Officer.
Acquisitions of Vian, CryoWorks, and Technifab strengthened the portfolio and contributed to sales.
Financial highlights
Q4 adjusted EPS was $1.26 (up from $0.80), and full-year adjusted EPS was $4.88, up 28% year-over-year.
Q4 adjusted operating profit was $96 million (up 38%), and full-year adjusted operating profit was $383 million, up 29%.
Q4 adjusted EBITDA was $108 million (19.8% margin); full-year adjusted EBITDA was $426.7 million (20.0% margin).
Q4 adjusted free cash flow was $193 million; full-year adjusted free cash flow was $234 million, exceeding the prior year.
Year-end cash was $307 million, total debt $247 million, and dividend increased by 12%.
Outlook and guidance
2025 adjusted EPS guidance is $5.30–$5.60, reflecting 12% growth at midpoint.
2025 revenue guidance is $2,230–$2,270 million, with 4–6% core growth, 1–2% from acquisitions, and a 1-point FX headwind.
Adjusted segment operating margin targeted at 22.5%+; free cash flow conversion expected to exceed 90%.
Anticipates another strong year with robust M&A pipeline and capital deployment opportunities.
Corporate cost expected at $80 million; adjusted tax rate at 23.5%; diluted shares ~59 million.
Latest events from Crane Company
- Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Record 2025 growth and acquisitions set up 10% adjusted EPS growth for 2026.CR
Q4 20252 Feb 2026 - Q2 sales up 14% and adjusted EPS up 18%, with raised full-year guidance and strong segment growth.CR
Q2 20242 Feb 2026 - Q3 2024 saw 13% sales growth, 34% higher EPS, and raised full-year guidance.CR
Q3 202418 Jan 2026 - Strong growth, margin expansion, and disciplined M&A set the stage for doubling business size.CR
Gabelli Funds 35th Annual Pump, Valve & Water Symposium7 Jan 2026 - Q1 2025 saw strong sales and profit growth, record backlog, and reaffirmed EPS guidance.CR
Q1 202525 Dec 2025 - Proxy details director elections, auditor ratification, and performance-based executive pay.CR
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting with no fee required.CR
Proxy Filing1 Dec 2025 - Q2 sales up 9.2%, adjusted EPS up 24%, guidance raised, and major PSI acquisition announced.CR
Q2 20253 Nov 2025